A hollow extrusion-molded body includes a resin composition that contains a base resin composed of an ethylene-ethyl acrylate copolymer or an ethylene-ethyl acrylate copolymer and a linear low-density polyethylene, a brominated flame retardant, antimony trioxide, and magnesium hydroxide having an average particle size of 0.5 m to 3.0 m. In the hollow extrusion-molded body, a composition ratio of the ethylene-ethyl acrylate copolymer to the linear low-density polyethylene, a content of the brominated flame retardant, a content of the antimony trioxide, and a content of the magnesium hydroxide are within specific ranges.

A glass container for storing pharmaceutical formulations may include a glass body formed from a Type IA or Type IB glass composition according to ASTM Standard E438-92(2011). The glass body may include a wall portion with an inner surface and an outer surface, a heel portion and a floor portion, wherein the inner surface of the glass container is formed by the inner surface of the glass body. The glass body may include at least a class A2 base resistance or better according to ISO 695, at least a type HGB2 hydrolytic resistance or better according to ISO 719 and Type 1 chemical durability according to USP <660>. The glass container does not comprise a boron-rich layer on the inner surface of the glass body in as formed condition.

A coated glass pharmaceutical package includes a glass body having a Type 1 chemical durability according to USP 660, at least a class A2 base resistance or better according to ISO 695, and at least a type HGB2 hydrolytic resistance or better according to ISO 719, the glass body having an interior surface and an exterior surface and a wall extending therebetween. A lubricous coating having a thickness of less than or equal to 90 nm may be positioned on at least a portion of the exterior surface of the glass body but not on any portion of the interior surface. The portion of the coated glass package with the lubricous coating comprises a coefficient of friction that is at least 20% less than an uncoated glass package and the coefficient of friction does not increase by more than 30% after undergoing a depyrogenation cycle including exposure to a temperature of 250? C. for a time period of 30 minutes. A horizontal compression strength of the coated glass package is at least 10% greater than an uncoated glass package and the horizontal compression strength is not reduced by more than 20% after undergoing the depyrogenation cycle including exposure to a temperature of 250? C. for a time period of 30 minutes and then being abraded. The lubricous coating comprises a polymer.

The present invention is directed to packaging films comprising a coextruded film having alternating individual layers of glass and plastic. These packaging films may be used for flexible food and pharmaceutical packaging. These packaging films provide excellent oxygen and moisture barrier protection while having superior flexibility.

The present invention is directed to thermoformed packaging articles comprising a coextruded film having alternating individual layers of glass and plastic. These thermoformed packaging articles may be used for packaging oxygen- and/or moisture sensitive foods and pharmaceutical/medical/dental products.

A glass container and related methods of manufacturing and coating glass containers. An exterior glass surface of a glass container is coated with a hybrid sol-gel and heated to cross-link the hybrid sol-gel. The resulting cross-linked hybrid sol-gel coating on the exterior glass surface of the glass container has greater than 90% silicate-based material by weight.

A laminated or single layer glass cylinder and its method of making are disclosed. The laminated cylinder glass is a precursor component to enable making subsequent drawn tubing having high optical quality. The laminated cylinder glass may comprise a first layer of glass as a clad glass and a second layer of glass as a core glass. The second layer of glass may be bound to the first layer of glass. The second layer may have a higher CTE from about 510.sup.7/ C. to about 10010.sup.7/ C. than the first layer of glass. The first layer and second layer of glass may have different softening points within about 200 C. of each other. In some embodiments, the first layer and second layer of glass may have different softening points from about 50 C. to about 200 C. of each other.

A sterile glass pharmaceutical container or vessel such as, but not limited to, vials for holding pharmaceutical products or vaccines in a hermetic and/or sterile state. The sterile glass pharmaceutical container undergoes a strengthening process that produces compression at the surface and tension within the container wall. The strengthening process is designed such that the tension within the wall is great enough to ensure catastrophic failure of the pharmaceutical container, thus rendering the product unusable, should sterility be compromised by a through-wall crack. The tension is greater than a threshold central tension, above which catastrophic failure of the pharmaceutical container is guaranteed, thus eliminating any potential for violation of pharmaceutical integrity or sterility (such as stable cracks) in the glass packaging which are not easily identifiable in an otherwise seemingly intact pharmaceutical container.

The glass containers described herein have at least two performance attributes selected from resistance to delamination, improved strength, and increased damage resistance. In one embodiment, a glass container may include a body having an inner surface, an outer surface and a wall thickness extending between the outer surface and the inner surface. At least the inner surface of the body may have a delamination factor less than or equal to 10. A tenacious inorganic coating may be positioned around at least a portion of the outer surface of the body. The outer surface of the body with the tenacious inorganic coating may have a coefficient of friction less than or equal to 0.7.

In embodiments, a delamination resistant glass pharmaceutical package includes a glass body formed from a Type 1 Class glass composition according to ASTM Standard E438-92, the glass body having a wall portion with an inner surface and an outer surface. The glass body may have at least a class A2 base resistance or better according to ISO 695, at least a type HGB2 hydrolytic resistance or better according to ISO 719 and Type 1 chemical durability according to USP <660>. An interior region of the glass body may extend from about 10 nm below the inner surface and have a persistent layer homogeneity. The glass body may also have a surface region extending over the inner surface and having a persistent surface homogeneity such that the glass body is resistant to delamination.